iSpecimen Inc. (NASDAQ:ISPC) Short Interest Update

iSpecimen Inc. (NASDAQ:ISPC) was the target of a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 29,600 shares, a drop of 23.7% from the January 31st total of 38,800 shares. Based on an average daily trading volume, of 883,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 3.6% of the company’s shares are sold short.

Hedge Funds Weigh In On iSpecimen

A hedge fund recently bought a new stake in iSpecimen stock. Bridgeway Capital Management LLC bought a new stake in iSpecimen Inc. (NASDAQ:ISPC) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 21,800 shares of the company’s stock, valued at approximately $58,000. Bridgeway Capital Management LLC owned 2.27% of iSpecimen as of its most recent SEC filing. 13.62% of the stock is owned by institutional investors.

iSpecimen Price Performance

NASDAQ:ISPC opened at $1.54 on Tuesday. The business’s 50-day moving average is $2.28 and its two-hundred day moving average is $3.04. The firm has a market capitalization of $1.48 million, a PE ratio of -0.08 and a beta of 1.63. iSpecimen has a 12 month low of $1.54 and a 12 month high of $11.80.

iSpecimen Company Profile

iSpecimen Inc provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers.